Why Novo Nordisk Stock Crumbled Again Today
The hits just kept coming for beleaguered Ozempic and Wegovy maker Novo Nordisk (NYSE: NVO) on Thursday. The company, which has been slammed with investor sell-offs since cutting its guidance on Tuesday, fell by almost 6% as yet another analyst weighed in with a bearish take on its prospects. The S 500 index, meanwhile, traded down only slightly.
That pundit was 's Rajesh Kumar, who downgraded his recommendation on Novo Nordisk that morning.
Image source: Getty Images.
Source Fool.com
HSBC Holdings plc Stock
€11.54
-1.550%